Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |